SNTI icon

Senti Biosciences
SNTI

Overview Fund Activity

22 hedge funds and large institutions have $44.4M invested in Senti Biosciences in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 34 closing their positions.

Holders
22
Holders Change
-23
Holders Change %
-51.11%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
4
Reduced
6
Closed
34
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NMC
1
NEA Management Company
Maryland
$7.46M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$7M
3
CCM
3
CAAS Capital Management
New York
$1.49M
4
IC
4
Intel Corp
California
$1.17M
5
AG
5
Artal Group
Luxembourg
$2.07M

Top Sellers

1
WP
1
Woodline Partners
California
$0
2
SC
2
Sculptor Capital
New York
$0
3
Marshall Wace
3
Marshall Wace
United Kingdom
$0
4
FTCM
4
First Trust Capital Management
Illinois
$0
5
MF
5
Magnetar Financial
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
HF
51
HRT Financial
New York
– – -29,381 Closed
RCM
52
Radcliffe Capital Management
Pennsylvania
– – -20,885 Closed
OAC
53
OMERS Administration Corp
Ontario, Canada
– – -17,007 Closed
UBS Group
54
UBS Group
Switzerland
$0 10 -2,139 -100%
Toronto Dominion Bank
55
Toronto Dominion Bank
Ontario, Canada
– – -75 Closed
CFGS
56
Concourse Financial Group Securities
Alabama
– – – –
CS
57
Clear Street
New York
$0 5 +5 New
1 2
3